Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01093859 | An Exploratory Phase 1 Microdose Study of PRX-105 | EARLY_PHASE1 | COMPLETED | 10 | — | — | Mar 1, 2010 | Aug 1, 2010 | Sep 4, 2012 | - | — |
| Name | Type | Description |
|---|---|---|
| PRX-105 | DRUG | Sterile solution for intravenous injection |